StockData
Xencor Inc logo

Xencor Inc (XNCR) stock

XNCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30194% above fair value
$34.39−0.11 (-0.32%)

Close on Nov 18, 2026Market cap $2.56BP/E –Yield –

Xencor market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Xencor's market cap was $2.97B on Nov 11, 2026, against $1.24B a year earlier. Over the last 5 years it ranged from $559.13M to $2.97B, with a median of $1.33B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$2.97B+172.0%
2025Dec 31, 2025$1.09B-32.1%
2024Dec 31, 2024$1.61B+24.8%
2023Dec 29, 2023$1.29B-17.3%
2022Dec 30, 2022$1.56B-33.6%
2021Dec 31, 2021$2.35B-6.3%
2020Dec 31, 2020$2.50B+28.3%
2019Dec 31, 2019$1.95B-4.0%
2018Dec 31, 2018$2.03B+97.5%
2017Dec 29, 2017$1.03B-4.9%
2016Dec 30, 2016$1.08B+83.0%
2015Dec 31, 2015$591.77M+17.6%
2014Dec 31, 2014$503.04M+76020.9%
2013Dec 31, 2013$660.84K–

More Xencor figures

See a number that looks wrong?